Skip to content
Diffuse Bio logo

Diffuse Bio

Hiring

Diffuse Bio is a YC Winter 2023 (W23) company. Based in San Carlos, CA, USA. Team of 10.

  • AI-powered Drug Discovery
  • Deep Learning
  • Generative AI
  • Machine Learning
  • Biotech

About Diffuse Bio

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Diffuse Bio develops generative AI tools for designing novel proteins, targeting researchers and drug developers who need precise control over protein structure and sequence. The platform produces biologically validated outputs at scale, replacing slow, trial-and-error wet-lab iteration with AI-driven generation. The team's work spans both diffusion-based sequence design and experimental confirmation of AI-created proteins.

From the Y Combinator listing

How Diffuse Bio describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Generative AI for protein design

Diffuse is building generative AI for protein design. Our mission is to build AI systems that engineer new and useful proteins with unprecedented control and accuracy. Our team has been behind breakthroughs in AI protein design for the past 7 years, including the first experimental validation of AI-generated proteins and diffusion models for protein structure and sequence.

Facts

Industry
Healthcare / Healthcare -> Drug Discovery and Delivery
Location
San Carlos, CA, USA
Team size
10
Status
Active
Stage
Early

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works